C

Cidara Therapeutics

61 employees

Cidara Therapeutics is a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing cancer and other serious diseases.

Investor insights

Funding rounds participated in

$105M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

2013

Funding rounds raised

Total raised

$105M

from 2 investors over 1 rounds

C

Cidara Therapeutics raised $105M on December 21, 2024

Investors: Venrock Healthcare Capital Partners and + 6 Other investors